SNSE SCHEDULE 13G/A: SEC filing

Faeth Therapeutics, Inc.

Filed with the SEC on Aug 14, 2026 · accession 0001727492-26-000018

SNSE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Faeth Therapeutics, Inc. (FTH) filed a Schedule 13G/A, an amendment to a passive ownership disclosure, indicating a change in a holder's beneficial ownership position.

Summary of the filing

Faeth Therapeutics, Inc. (FTH) filed a Schedule 13G/A, an amendment to a passive ownership disclosure, indicating a change in a holder's beneficial ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

For details, click here →

Key details

IssuerFaeth Therapeutics, Inc.

✦ Ask GOAX AI about this filing — what it means for SNSE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SNSE?

Click here

Frequently asked questions

What did SNSE file with the SEC on Aug 14, 2026?

SNSE filed a SCHEDULE 13G/A (SEC filing). Faeth Therapeutics, Inc. (FTH) filed a Schedule 13G/A, an amendment to a passive ownership disclosure, indicating a change in a holder's beneficial ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other SNSE SEC filings

Get alerts when SNSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SNSE overview SNSE analysis SNSE news Latest SEC filings